Gall Bladder Cancer

Audrey E. Ertel, David Bentrem, Daniel E. Abbott

Research output: Contribution to journalReview article


Gallbladder carcinoma (GBC) is the most common biliary epithelial malignancy, with an estimated 10,910 new cases and 3700 deaths per year (Siegel et al. in CA Cancer J Clin 65:5–29, 2015 [1]). This disease’s insidious nature and typically late presentation place it among the most lethal of invasive neoplasms. Gallbladder cancer spreads early by lymphatic or hematogenous metastasis and by direct invasion into the liver. While surgery may well be curative at early stages, both surgical and nonsurgical treatments remain largely unsuccessful in patients with more advanced disease.

Original languageEnglish (US)
Pages (from-to)101-120
Number of pages20
JournalCancer Treatment and Research
StatePublished - Jan 1 2016


ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Ertel, A. E., Bentrem, D., & Abbott, D. E. (2016). Gall Bladder Cancer. Cancer Treatment and Research, 168, 101-120.